Charles Ryhee

Stock Analyst at TD Cowen

(2.47)
# 2,488
Out of 5,033 analysts
17
Total ratings
60%
Success rate
11.09%
Average return

Stocks Rated by Charles Ryhee

CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73$80
Current: $82.48
Upside: -3.01%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563$652
Current: $787.82
Upside: -17.24%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185$170
Current: $154.48
Upside: +10.05%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57$59
Current: $7.76
Upside: +660.31%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59$72
Current: $157.27
Upside: -54.22%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240$188
Current: $8.98
Upside: +1,993.54%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $20.18
Upside: +43.71%